Yin Chen Hao — Artemisia capillaris

Taxonomy, and the Yerba Lena Yesca mislabel

The Western herb trade sells this plant as Yerba Lena Yesca and markets it as a legal psychoactive or smoking herb. That framing is wrong twice over. It is not supported by any pharmacological literature, and it actively obscures what the plant is: the principal hepatoprotective and choleretic herb of the Chinese materia medica, with a documented indication (jaundice) that is stable across two millennia of transmitted text.

The genus is a live identification hazard in both directions. Artemisia contains A. absinthium (wormwood, the thujone plant), A. annua (source of artemisinin), A. scoparia (frequently traded as Yin Chen and pharmacopoeially accepted as such in some standards), A. iwayomogi (a documented East Asian substitute, distinguishable analytically by its bioactive profile) and dozens of others. Dried aerial Artemisia material is not easy to identify by eye. Buying 'Artemisia' or an ambiguous trade name and assuming you have A. capillaris is how a person ends up consuming thujone or artemisinin instead of scoparone.

The plant also changes name within the Chinese tradition according to when it was gathered, which is covered in the harvest-timing section and is a genuine part of its identity rather than a curiosity.

• A. capillaris: scoparone and capillarisin — the liver herb
• A. absinthium: thujone — a GABA-A antagonist and convulsant at dose
• A. annua: artemisinin — an antimalarial sesquiterpene lactone endoperoxide
• A. scoparia and A. iwayomogi: traded as or alongside Yin Chen; different bioactive profiles
• 'Yerba Lena Yesca' and 'psychoactive' are market framings, not pharmacology

Sources: Jung J 2023 · Lachenmeier DW 2008 · Klayman DL 1985 · Harada R 1982

Phytochemistry

The plant's activity is carried by two coumarins, a set of caffeoylquinic acids, a flavonoid fraction, polysaccharides, and a volatile oil. Scoparone is the marker compound for identity and potency, and validated analytical methods for it exist precisely because content varies so much with harvest stage and with species substitution.

Sources: Okuno I 1988 · Hanh NTT 2026 · Tan Y 2026 · Cai Y 2024 · Harada R 1982 · Jung J 2023 · Gertsch J 2008

Pharmacology by mechanism animal

Choleretic. This is the oldest and best-characterised action: the herb increases bile flow and alters bile composition, increasing secretion of bile acids, phospholipids and cholesterol, and promoting gallbladder contraction. The choleretic constituents were isolated and characterised as such in the 1980s, which is unusually early and unusually specific for a traditional herb — the mechanism was not retrofitted onto the indication, it was found to match it.

Hepatoprotective. Across chemical-injury models the herb and its isolated coumarins reduce hepatocyte necrosis, preserve membrane integrity and support regeneration. Capillarisin has recently been shown to protect against acetaminophen hepatotoxicity by targeting a GSK3-beta/Nrf2 axis and suppressing ferroptosis, which is a specific and current mechanism rather than a general antioxidant hand-wave.

Anti-inflammatory. Reduction of serum transaminases in injury models is the standard readout, and reflects reduced hepatocellular damage rather than a direct effect on the enzymes.

Antioxidant and Nrf2-linked. Both the small-molecule and polysaccharide fractions converge on Nrf2 activation, which is also the mechanism through which the classical multi-herb Yinchenhao decoction acts in obstructive-jaundice models.

Antisteatotic. Reduction of hepatic cholesterol and triglyceride content is reported in animal models.

Gut-microbiota-mediated. The polysaccharide work shows that part of the effect does not require systemic absorption of the herb at all, operating instead through microbiota modulation — which matters for interpreting preparation differences, since polysaccharides survive a water decoction and would be absent from an alcoholic extract.

Sources: Okuno I 1988 · Tan Y 2026 · Cai Y 2024 · Liu J 2022 · Yang Y 2023 · Hanh NTT 2026

Scoparone in detail contested in vitro

Scoparone is 6,7-dimethoxycoumarin: a benzopyranone with two methoxy groups on the benzene ring. The methoxylation matters. Simple coumarin — the unsubstituted parent, the one in cassia cinnamon and tonka bean — has a documented human hepatotoxicity signal and a tolerable-daily-intake set on that basis. Scoparone is a different molecule with a different metabolic fate, and it should not be assumed to carry simple coumarin's toxicity; equally, it should not be assumed not to, since the class relationship is real and its own human toxicology is thin.

Pharmacologically scoparone is the workhorse: choleretic, anti-inflammatory, vasorelaxant in some preparations, and hepatoprotective across models. A dedicated review of the compound now exists, which is a reasonable marker of how much attention it has received relative to the rest of the plant.

One finding in the operator's source material needs handling carefully: scoparone has been reported to increase dopamine release in PC12 cells. PC12 is a rat adrenal pheochromocytoma cell line used as a catecholaminergic model. An increase in dopamine release from a cultured tumour cell line is a mechanistic observation in a dish. It is not evidence of a dopaminergic effect in a person, it does not support the 'psychoactive' marketing of the plant, and it cannot be read across to mood, motivation or reward. Stated at its actual weight it is an interesting lead; stated as a reason to smoke the plant it is a misrepresentation.

Contested — caveat. The dopamine-release finding is in vitro only, in a rat tumour cell line, from a single report. It does not establish any dopaminergic effect in humans and does not support psychoactive marketing of this plant.

Sources: Hanh NTT 2026 · Yang H 2010 · Abraham K 2010 · EFSA Scientific Panel on Food Additives 2004

Harvest timing, and the name that changes with the season contested historical / ethnographic

Chinese practice treats gathering time as part of the identity of this drug, not as a quality nicety. The proverb runs: 'Yin Chen in the second month, Hao in the third, and in the fifth month Yin Chen is fit only for firewood' — in characters, 二月茵陳三月蒿，五月茵陳當柴燒.

What that encodes is a potency curve. The young spring shoots carry the bioactive load; as the plant bolts and matures through summer the coumarin content falls and the material becomes, in the proverb's judgement, fuel. The drug name follows the calendar: the spring-gathered material is Yin Chen Hao, the later summer material is distinguished as Mian Yin Chen. A single botanical species therefore supplies two differently-named and differently-valued drugs depending on when it was cut.

The analytical literature supports the underlying claim in the sense that scoparone content in A. capillaris is variable enough to require a validated quantitative method for quality control, and differs measurably between A. capillaris and its common substitute A. iwayomogi. A published quantitative harvest-month curve tying scoparone content to the proverb is not something we can cite, so the proverb should be read as a well-founded traditional potency heuristic rather than as a calibrated specification.

Contested — caveat. The harvest-timing proverb is a traditional potency heuristic with strong internal logic and analytical plausibility. We are not citing a published month-by-month quantitative content curve for scoparone that confirms it.

Sources: Attributed to Shennong; compiled in the Han period* · Jung J 2023 · Hanh NTT 2026

The liver-brain axis contested

The liver is upstream of the brain in three documented ways, and this is the mechanistic frame in which a liver herb gets discussed alongside nootropics.

Ammonia clearance. The urea cycle is hepatic. When hepatic function fails, ammonia rises and crosses into the brain, where astrocytes detoxify it to glutamine — with osmotic swelling, altered glutamatergic transmission and mitochondrial dysfunction as consequences. That is the central pathogenic mechanism of hepatic encephalopathy, a real and gradable neuropsychiatric syndrome that runs from subtle attentional deficits through to coma.

Bile-acid signalling. Bile acids are not only detergents; they are ligands for the nuclear receptor FXR and the membrane receptor TGR5, and they signal in tissues well beyond the gut and liver. Bile-acid pool composition is altered in liver disease, and the classical Yinchenhao decoction's activity in obstructive jaundice runs partly through bile-acid handling and Nrf2 signalling.

Clearance capacity generally. Phase I and phase II metabolism and biliary excretion are the body's route for eliminating a large class of xenobiotics and endogenous neuroactive metabolites. Reduced hepatic clearance raises exposure to all of them.

What follows from this, and what does not. It follows that hepatic function is a genuine determinant of cognitive function, and that in established liver disease this is clinically central. It does not follow that a hepatoprotective herb improves cognition in a person with a normal liver. That extrapolation — from 'the liver matters for the brain' to 'this liver herb is a nootropic' — is not demonstrated for A. capillaris and there is no trial of it as a cognitive intervention. The mechanism is real; the inference is not licensed by it.

Contested — caveat. The liver-brain mechanisms cited are well established in hepatology. The extension to cognitive benefit from A. capillaris in people without liver disease is an extrapolation with no supporting trial.

Sources: Wijdicks EFM 2016 · Albrecht J 2012 · Liu J 2022 · Yang Y 2023

Preparation-relevant chemistry (properties, not procedure)

Scoparone is a dimethoxycoumarin: a small, essentially neutral, moderately lipophilic molecule. It is poorly soluble in water and substantially better soluble in ethanol and in other organic solvents. A water decoction therefore carries less scoparone per gram of herb than an alcoholic preparation of the same material — which is worth knowing, because the classical use is a decoction while the pharmacological literature frequently studies alcoholic or methanolic extracts, and the two are not the same preparation.

Capillarisin is a chromone-type structure, more polar than scoparone, and is carried reasonably by aqueous-alcoholic media.

The caffeoylquinic acids, chlorogenic acid among them, are water-soluble and are what a decoction delivers well. They are also the most labile fraction: caffeoylquinic acids isomerise under heat (the 3-, 4- and 5-caffeoylquinic acid positional isomers interconvert), hydrolyse under alkaline conditions, and oxidise. Prolonged boiling reduces and rearranges them rather than simply extracting them.

The polysaccharide fraction is water-soluble, alcohol-insoluble and heat-stable, so it is present in a decoction and absent from a tincture. Given that the polysaccharide work shows a microbiota-mediated route to the same hepatoprotective endpoint, a decoction and a tincture of this plant are pharmacologically distinct in a way that goes beyond potency.

The essential oil — beta-caryophyllene, alpha-humulene, capillene and the rest — is volatile and largely lost from an open, prolonged decoction. It is what a vapour or a short infusion would carry. Coumarins are appreciably volatile at elevated temperature (this is why coumarin-bearing plants smell of hay), so a thermal route does mobilise some scoparone, but a coumarin also has a limited thermal window before decomposition and no specified band for it is given here.

What degrades in storage: the volatile fraction goes first; caffeoylquinic acids oxidise and brown; coumarins are relatively robust but photodegrade. Cool, dark and dry is the standard, as for any aromatic Asteraceae.

No extraction procedure, solvent system, ratio, temperature, duration or process yield is given in this corpus.

Sources: Hanh NTT 2026 · Cai Y 2024 · Harada R 1982 · Jung J 2023

Interactions and cautions, with the mechanism named

This is a coumarin-bearing hepatotropic herb. That combination defines its caution profile, and it is the opposite of an inert tonic.

Do not stack it casually with CYP inhibitors. The herb's whole point is hepatic action. Adding a deliberate cytochrome P450 inhibitor — grapefruit furanocoumarins, piperine, curcuminoids, or another kava-style inhibitor — on top of a hepatotropic coumarin herb means you have raised and made unpredictable the hepatic exposure to both. The practice of 'potentiating' herbs with CYP inhibitors is specifically hazardous when the herb being potentiated is one whose target organ is the liver. There is no characterised human CYP profile for A. capillaris, so the direction and size of the interaction is unknown rather than benign.

Do not stack it with other hepatotoxicity-signal botanicals. Kava (organic-solvent extracts especially), pyrrolizidine-alkaloid-bearing plants (comfrey, borage, coltsfoot), high-dose concentrated green tea catechin extracts, black cohosh and germander all carry hepatic signals of varying strength. Combining several botanicals that each produce occasional hepatic injury is how an idiosyncratic single-agent risk becomes a probable multi-agent one, and it is also how causality becomes impossible to assign afterwards.

Coumarin class toxicology is a real body of evidence. Simple coumarin has a human hepatotoxicity signal, a defined tolerable daily intake and a documented subpopulation of susceptible individuals. Scoparone and capillarisin are substituted coumarins with different metabolism and cannot be assigned simple coumarin's numbers — but the class relationship is why a coumarin-bearing herb taken for the liver deserves the same monitoring discipline as any other hepatically-active agent, and why long continuous high-dose use is not the same proposition as short courses.

Biliary obstruction. A choleretic increases bile production. In complete mechanical biliary obstruction, increasing bile production without an outflow route is mechanistically the wrong intervention. The classical formula is used for cholestatic jaundice within a diagnostic tradition that distinguishes patterns; the isolated herb bought online carries no such gating.

Anticoagulants. Coumarin-bearing plants attract a reflexive warfarin warning. The honest mechanistic position: coumarin itself is not an anticoagulant (4-hydroxycoumarin derivatives such as warfarin and dicoumarol are), and there is no evidence that scoparone or capillarisin has vitamin K antagonist activity. The real concern with this herb and warfarin is not structural analogy but the possibility of altered hepatic metabolism of a narrow-therapeutic-index CYP2C9 substrate by an uncharacterised hepatotropic herb.

'Psychoactive' marketing is not supported. There is no pharmacological basis in the literature for A. capillaris as a psychoactive or smoking herb. The single in-vitro dopamine-release observation does not constitute one.

Asteraceae sensitisation, as for all daisy-family material: contact dermatitis, cross-reactivity with ragweed and other Asteraceae, occasional systemic allergy.

Misidentification is a toxicological hazard, not just a quality one. A. absinthium brings thujone, a GABA-A antagonist and convulsant at sufficient dose. A. annua brings artemisinin. Neither is what the buyer thinks they purchased.

Pregnancy and lactation: Artemisia species as a group carry traditional emmenagogue and abortifacient reputations and A. capillaris is not characterised in pregnancy. Treat as contraindicated absent data.

Sources: Abraham K 2010 · EFSA Scientific Panel on Food Additives 2004 · Teschke R 2009 · Lachenmeier DW 2008 · Klayman DL 1985 · Yang H 2010 · Mullins RJ 2002 · Flockhart DA 2021*

What is not known

There is no human pharmacokinetic study of scoparone or capillarisin that we can cite — no oral bioavailability figure, no half-life, no metabolite map in humans. For a compound with a two-thousand-year clinical record that is a striking gap.

Almost all of the hepatoprotective pharmacology is rodent and cell-culture work. The human clinical material is overwhelmingly about Yinchenhao Tang, the multi-herb decoction, not about A. capillaris alone — so the single-herb contribution to the formula's documented effect is inferred rather than measured.

There is no characterised human cytochrome P450 inhibition or induction profile for the herb or its coumarins, which is exactly the datum needed to reason properly about the interaction cautions above.

Dose-response in humans is unestablished. Traditional decoction quantities exist in the formulary literature; equivalent doses for concentrated extracts, standardised products or isolated scoparone do not.

The harvest-timing potency curve is traditional and plausible but not, so far as we can cite, published as a quantitative month-by-month measurement.

Whether the essential-oil fraction, including its beta-caryophyllene, contributes materially to the herb's documented hepatic effect, or is simply along for the ride, has not been separated out.

Sources: Hanh NTT 2026 · Liu J 2022 · Yang Y 2023 · Cai Y 2024 · Jung J 2023